Results 21 to 30 of about 76,712 (310)

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Annals of the Rheumatic Diseases, 2022
Objective To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2022 update of the Assessment of SpondyloArthritis international Society ...
C. Webers, A. Ortolan, A. Sepriano, L. Falzon, X. Baraliakos, Robert B. M. Landewé, S. Ramiro, D. van der Heijde, E. Nikiphorou   +8 more
semanticscholar   +1 more source

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages [PDF]

, 2016
Introduction: The Assessments of SpondyloArthritis international society Health Index (ASAS HI) measures functioning and health in patients with spondyloarthritis (SpA) across 17 aspects of health and 9 environmental factors (EF).
Bautista-Molano, W, Boonen, A, Braun, J, Burgos-Vargas, R, Chiowchanwisawakit, P, Duruoz, T, El-Zorkany, B, Essers, I, Gaydukova, I, Gossec, L, Grazio, S, Gu, J, Géher, P, Khan, MA, Kiltz, U, Kim, TJ, Maksymowych, WP, Marzo-Ortega, H, Navarro-Compán, V, Olivieri, I, Patrikos, D, Pimentel-Santos, FM, Schirmer, M, Van den Bosch, Filip, van der Heijde, D, Weber, U, Zochling, J   +26 more
core   +9 more sources

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis

Advances in Rheumatology, 2019
Background In recent decades, obesity has become a public health problem in many countries. The objective of this study was to evaluate the main joint and extra-articular manifestations related to spondyloarthritis (SpA) after bariatric surgery (BS) in a
Thauana Luiza de Oliveira, Hilton Telles Libanori, Marcelo M. Pinheiro   +2 more
doaj   +1 more source

Understanding the Pathogenesis of Spondyloarthritis

Biomolecules, 2020
Spondyloarthritis comprises a group of inflammatory diseases of the joints and spine, with various clinical manifestations. The group includes ankylosing spondylitis, reactive arthritis, psoriatic arthritis, arthritis associated with inflammatory bowel ...
Aigul Sharip, Jeannette Kunz
doaj   +1 more source

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study [PDF]

, 2015
Objective: To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA).
Bonin, Randi, Braun, Jürgen, Bukowski, Jack F, Citera, Gustavo, Dougados, Maxime, Jones, Heather, Kotak, Sameer, Logeart, Isabelle, Maksymowych, Walter P, Marshall, Lisa, Pedersen, Ron, Sieper, Joachim, Van den Bosch, Filip, van der Heijde, Désirée, Vlahos, Bonnie, Wajdula, Joseph   +15 more
core   +1 more source

Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease

Arthritis & Rheumatology, 2023
Spondyloarthritis (SpA) is a group of immune‐mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders, such as acute anterior uveitis (AAU) and Crohn's disease (CD). The gut microbiome represents a promising avenue to elucidate
Morgan Essex, V. Rios Rodriguez, J. Rademacher, F. Proft, U. Löber, Lajos Markó, Uwe Pleyer, Till Strowig, Jérémy Marchand, J. Kirwan, B. Siegmund, S. Forslund, Denis Poddubnyy   +12 more
semanticscholar   +1 more source

Cardiovascular risk in axial spondyloarthritis—a systematic review

Clinical Rheumatology, 2023
Cardiovascular manifestations are common in patients suffering axial spondyloarthritis and can result in substantial morbidity and disease burden.
Rainer Hintenberger, Barbara Affenzeller, Valeriia Vladychuk, H. Pieringer   +3 more
semanticscholar   +1 more source

Diagnostic value of MRI of the sacroiliac joints in juvenile spondyloarthritis [PDF]

, 2016
Early diagnosis of spondyloarthritis (SpA) is becoming more important as new medical treatment options have become available to treat inflammation and delay progression of the disease.
Baraliakos, Xenofon, Dehoorne, Jo, Herregods, Nele, Jans, Lennart, Jaremko, Jacob, Joos, Rik, Verstraete, Koenraad   +6 more
core   +1 more source

Spondyloarthritis [PDF]

, 2020
The global aim of this thesis was to accelerate the patient journey from first symptoms to adequate treatment in spondyloarthritis (SpA) by a) tailoring the diagnostic process in order to enable an earlier diagnosis and b) tailoring the treatment strategy to shorten the time from diagnosis to remission and to increase remission rates in patients with ...
openaire   +4 more sources

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Annals of the Rheumatic Diseases, 2022
Objective To update the evidence of non-biological treatments for axial spondyloarthritis (axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society-European Alliance of Associations for Rheumatology (ASAS-EULAR ...
A. Ortolan, C. Webers, A. Sepriano, L. Falzon, X. Baraliakos, Robert B. M. Landewé, S. Ramiro, D. van der Heijde, E. Nikiphorou   +8 more
semanticscholar   +1 more source